# Nerlynx

NDC: 70437-240
Generic name: neratinib
Labeler / Manufacturer: Puma Biotechnology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170717

FDA application: NDA208051

## Active ingredients

- NERATINIB MALEATE ANHYDROUS: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70437-240"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70437-240
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1e41dcf-e82a-47c2-a0ad-6c6eef621834